Found: 24
Select item for more details and to access through your institution.
Exosomal miR-141 promotes tumor angiogenesis via KLF12 in small cell lung cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. N.PAG, doi. 10.1186/s13046-020-01680-1
- By:
- Publication type:
- Article
Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.783495
- By:
- Publication type:
- Article
Avoiding Absolute Quantification Trap: A Novel Predictive Signature of Clinical Benefit to Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.782106
- By:
- Publication type:
- Article
Development and external validation of a composite immune-clinical prognostic model associated with EGFR mutation in East-Asian patients with lung adenocarcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211006949
- By:
- Publication type:
- Article
Development and external validation of a composite immune-clinical prognostic model associated with EGFR mutation in East-Asian patients with lung adenocarcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211006949
- By:
- Publication type:
- Article
Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 5, p. 2429, doi. 10.1002/cam4.2115
- By:
- Publication type:
- Article
S100A7 as a potential diagnostic and prognostic biomarker of esophageal squamous cell carcinoma promotes M2 macrophage infiltration and angiogenesis.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 7, p. 1, doi. 10.1002/ctm2.459
- By:
- Publication type:
- Article
Combined detection of aneuploid circulating tumor‐derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non‐small‐cell lung cancer.
- Published in:
- Clinical & Translational Medicine, 2020, v. 10, n. 3, p. 1, doi. 10.1002/ctm2.128
- By:
- Publication type:
- Article
A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma.
- Published in:
- Cancer Biology & Medicine, 2021, v. 18, n. 3, p. 734, doi. 10.20892/j.issn.2095-3941.2020.0397
- By:
- Publication type:
- Article
Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 768, doi. 10.20892/j.issn.2095-3941.2020.0121
- By:
- Publication type:
- Article
Survival-associated alternative splicing signatures in esophageal carcinoma.
- Published in:
- Carcinogenesis, 2019, v. 40, n. 1, p. 121, doi. 10.1093/carcin/bgy123
- By:
- Publication type:
- Article
TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 10, p. 1, doi. 10.1038/s41419-021-04155-z
- By:
- Publication type:
- Article
The membrane-bound and soluble form of melanotransferrin function independently in the diagnosis and targeted therapy of lung cancer.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 10, p. 1, doi. 10.1038/s41419-020-03124-2
- By:
- Publication type:
- Article
The average copy number variation (CNVA) of chromosome fragments is a potential surrogate for tumor mutational burden in predicting responses to immunotherapy in non‐small‐cell lung cancer.
- Published in:
- Clinical & Translational Immunology, 2021, v. 10, n. 1, p. 1, doi. 10.1002/cti2.1231
- By:
- Publication type:
- Article
KRAS‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer.
- Published in:
- Cancer Communications, 2022, v. 42, n. 9, p. 828, doi. 10.1002/cac2.12327
- By:
- Publication type:
- Article
Single-cell analysis reveals the potential mechanisms of pyrotinib resistance in non-small cell lung cancer.
- Published in:
- 2023
- By:
- Publication type:
- Letter
S100A7 attenuates immunotherapy by enhancing immunosuppressive tumor microenvironment in lung squamous cell carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Systematic profiling of immune signatures identifies prognostic predictors in lung adenocarcinoma.
- Published in:
- Cellular Oncology (2211-3428), 2020, v. 43, n. 4, p. 681, doi. 10.1007/s13402-020-00515-7
- By:
- Publication type:
- Article
Analysis of functional hub genes identifies CDC45 as an oncogene in non-small cell lung cancer - a short report.
- Published in:
- Cellular Oncology (2211-3428), 2019, v. 42, n. 4, p. 571, doi. 10.1007/s13402-019-00438-y
- By:
- Publication type:
- Article
Tumor microenvironment characterization identifies two lung adenocarcinoma subtypes with specific immune and metabolic state.
- Published in:
- Cancer Science, 2020, v. 111, n. 6, p. 1876, doi. 10.1111/cas.14390
- By:
- Publication type:
- Article
The TGFβ-Induced Long Non-coding RNA TBULC Promotes the Invasion and Migration of Non-small Cell Lung Cancer Cells and Indicates Poor Prognosis.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01340
- By:
- Publication type:
- Article
Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity.
- Published in:
- 2019
- By:
- Publication type:
- journal article